Darier's disease is a rare genetic skin disorder characterized by wart-like papules, skin thickening, and nail abnormalities. The ICD-10 code for Darier's disease is L85.0. In the previous coding system, the ICD-9 code for this condition was 757.39. These codes are used by healthcare professionals for accurate diagnosis and billing purposes.
Darier's disease, also known as Darier-White disease or keratosis follicularis, is a rare genetic skin disorder that affects the skin's integrity, primarily in areas such as the scalp, forehead, chest, back, and nails. It is characterized by the presence of small, firm, wart-like papules that may converge into plaques, as well as other manifestations such as nail abnormalities and mucous membrane involvement.
In the International Classification of Diseases, 10th Revision (ICD-10), the specific code for Darier's disease is L85.3. This code falls under the category of "Other specified epidermal thickening" within the broader section of "Papulosquamous disorders." The ICD-10 code L85.3 is used to identify and classify cases of Darier's disease in healthcare settings for medical records, billing purposes, and statistical analysis.
In contrast, the International Classification of Diseases, 9th Revision (ICD-9), which was used prior to the implementation of ICD-10, provided a different code for Darier's disease. The corresponding ICD-9 code for Darier's disease was 757.39. This code fell under the category of "Other disorders of skin appendages" within the broader section of "Congenital anomalies." However, it is important to note that since the implementation of ICD-10 in most healthcare systems worldwide, the use of ICD-9 codes has become obsolete.
It is crucial for healthcare professionals to accurately assign the appropriate ICD-10 code for Darier's disease when documenting and coding patient encounters. This ensures proper identification and tracking of the condition for clinical, administrative, and research purposes. The assigned code aids in facilitating communication between healthcare providers, researchers, and insurance companies, ultimately contributing to improved patient care and outcomes.